GMTA is the Global Medical Technology Alliance. Its members are national or regional medical technology associations, which represent innovative companies that currently develop and manufacture 85 percent of the world's medical devices, diagnostics and equipment. It provides a forum for the development and advocacy of policies that support innovation in medical technology to address patients' healthcare needs. Medical technologies save, support, and improve lives every day around the world. Please go to "About GMTA" for membership criteria and process, and for the governance rules.
Find out more about GMTA's governance, mission and objectives
The GMTA membership includes associations, which have member companies and, in some cases, other associations as members. Each association listed as a GMTA member maintains its own list of members. Inquiries about the membership of each association should be directed to that association.
= Founding members
ASSOCIATION NAME | ACRONYM / WEBSITE / CONTACT | COUNTRY / REGION | |
---|---|---|---|
Advanced Medical Technology Association | AdvaMed Ashley Miller Executive Vice President amiller@advamed.org |
United States | |
Argentine Chamber of Medical Products, Implants and Equipment |
CADIEM |
Argentina | |
Asia-Pacific Medical Technology Association | APACMED Harjit Gill Chief Executive Officer HGill@APACMed.org |
Asia-Pacific | |
|
ABHI |
UK | |
Association of National Enterprises of Colombia Medical Device Chamber | ANDI - CDMIS Marisol Sánchez Gomez Executive Director msanchez@andi.com.co |
Colombia | |
Association of Market Operators of Medical Devices | AMOMD Mrs. Darya Bondarenko (Doroshchuk) CEO doroshchuk@amomd.com |
Ukraine | |
Association of Research Based Medical Technology Manufacturers in Turkey | ARTED Ms. Elif Özman Pusat General Secretary genelsekreter@arted.org.tr |
Turkey | |
Brazilian High-Technology Health Products Industry Association | ABIMED Fernando Silveira Executive Director fernando.silveira@abimed.org.br |
Brazil | |
Brazilian Innovative Health Industry Alliance | ABIIS José Márcio Cerqueira Gomes Executive Director diretoria@abiis.org.br |
Brazil | |
Brazilian In-Vitro Diagnostics Chamber | CBDL Carlos Gouvea Executive Director cegouvea@gmail.com |
Brazil | |
Bundesverband Medizintechnologie | BVMed Dr. Marc-Pierre Möll Executive Director moell@bvmed.de |
Germany | |
Canada's Medical Technology Companies | MedTech Canada Nicole Dekort International Affairs ndekort@medtechcanada.org |
Canada | |
Chilean Medical Device Association | ADIMECH AG Gabriela Garnham Moccetti General Manager gabrielagarnham@adimech.cl |
Chile | |
Chinese Medical Devices Industry Association | CAMDI Jiang Feng Dr.jiangfeng@yahoo.com.cn and medicaljiang@163.com |
China | |
Ecuadorian Medical Product Distributers and Importers Association | ASEDIM Cristina Murgueitio Executive Director direccionejecutiva@asedim.com |
Ecuador | |
Inter-American Coalition for Regulatory Convergence for the Medical Technology Sector | Sandra Ligia González Executive Secretary sandra@interamericancoalition-medtech.org |
Western Hemisphere | |
International Medical Device Manufacturers Association | IMEDA Sergey Vanin Executive Director s.vanin@IMEDA.ru |
Russia | |
Irish Medical Devices Association | IMDA Aine Fox Director, IBEC aine.fox@ibec.ie |
Ireland | |
HeathTech Ireland Association | HealthTech Ireland Susan Treacy Chief Executive susan.treacy@healthtechireland.ie |
Ireland | |
IVD Australia Limited | IVD Australia Wendy-Jane Morrow CEO, IVD Australia ceo@ivd.org.au |
Australia | |
The Japan Federation of Medical Devices Associations | JFMDA Koji Sekiguchi koji.sekiguchi@hoya.com |
Japan | |
Korea Medical Device Industry Association | KMDIA Kate Kim hkim55@its.jnj.com KMDIA |
Korea | |
Medical Device Manufacturers Association | MDMA Edward Rozynski |
United States | |
Medical Imaging & Technology Alliance | MITA Patrick A. Hope phope@medicalimaging.org | United States | |
Medical Technology Association of Australia | MTAA Ian Burgess Chief Executive Officer Iburgess@mtaa.org.au |
Australia | |
Medical Technology Industry of Denmark | MEDICOINDUSTRIEN Peter Hundley Chief Executive Officer ph.medicoindustrien.dk |
Denmark | |
Medical Technology Association of Middle East and Africa | Mecomed Dr. Inna Nadelwais Executive Manager Inna.nadelwais@mecomed.com |
Middle East | |
Medical Technology Association of New Zealand | MTANZ Cushla Smyth Chief Executive Officer ushla@mtanz.org.nz |
New Zealand | |
MedTech Europe | MTE Jesus Rueda Director, International Affairs j.rueda@medtecheurope.org |
Europe | |
Mexican Association of Innovative Medical Devices | AMID Ana Riquelme Executive Officer Ana.riquelme@amid.org.mx |
Mexico | |
South African Medical Device Industry Association | SAMED Tanya Vogt Executive Officer Tanya@samed.org.za |
South Africa | |
Southern African Laboratory Diagnostics Association | SALDA Sarah Cohen Executive Officer exec@salda.org.za |
South Africa |
Global Medical Device Nomenclature | GMDN Deniz Bruce Chief Executive Officer deniz.bruce@gmdnagency.org |
Global |
GMTA Membership - May 2022 [PDF]
Members of the Global Medical Technology Alliance (GMTA) support the objectives of providing safe, effective and innovative medical technology that saves and enhances lives, benefiting people and society. The GMTA is a forum in which members exchange information and jointly develop and advocate policies that encourage innovation to address patients' healthcare needs.1
The objects or purpose of GMTA include:
The criteria for full membership include:
The criteria for associate membership include:
The criteria for affiliate membership include:
A potential member must submit a formal application in writing to the co-chairs of GMTA (see footnote 2) who will determine the eligibility of the applicant. The members of GMTA will formally accept or reject the application at the next GMTA meeting following submission of the application.
The following process applies for development and adherence to policy positions of GMTA.
Any GMTA member may present a draft policy paper for consideration by GMTA members. The paper should define the issue, provide background and present recommendations for GMTA consideration.
If the member wants the paper to be considered for discussion at the next GMTA meeting, the paper must be distributed at least 30 days in advance to allow members to consult their members. The paper should be sent to the current chair2 of the GMTA for immediate distribution to the entire membership. The paper will be discussed at the meeting, with a timetable established for decision making. The sponsor must also indicate how the proposal would be used – e.g., for a specific upcoming meeting of an international organization, for general advocacy with third parties, or for internal GMTA use.
The members of GMTA have agreed to an opt-in process for decision-making, in which a GMTA member must indicate to the GMTA chair that it is prepared to accept a proposal on behalf of the member association.
After a proposal is debated and, if needed, revised, the chair or the proponent may solicit each member's support. A member may, at that time, indicate: (a) support; (b) non-support; (c) still considering. If five or more GMTA members
If the GMTA approves a particular policy proposal, any members that could not initially support a proposal could opt-in at a later date. That is, those GMTA members in the (b) or (c) categories could indicate support when their membership has given approval.
Except as provided in this clause, no individual member of GMTA may use the GMTA logo or name or purport to represent GMTA. The logo and name may only be used on material reflecting the consensus position of GMTA members (as outlined in the previous paragraph), and to represent collective GMTA views and advocacy as agreed by GMTA members. A full member may use the logo and name on its website with a link to the GMTA website, to denote membership of GMTA. If the member ceases to be a member of GMTA it must immediately remove the logo, name and link to the GMTA website.
1 "Medical technology" is used here to mean medical devices, medical equipment and diagnostic products. This term does not include pharmaceuticals or vaccines.
2 The chair currently alternates between AdvaMed and Eucomed, with each association chairing GMTA for six months with AdvaMed from March to October, and Eucomed from October to the following March.
3 One of the main purposes of the GMTA is to reflect the medical technology industry's views on a global basis. In that respect, associations in the GMTA should have members that operate internationally and not sell just in their respective home country markets.
GMTA is the Global Medical Technology Alliance.
Its members are national or regional medical technology associations, which represent innovative companies that currently develop and manufacture over 85 percent of the world's medical devices, diagnostics and equipment.
It provides a forum for the development and advocacy of policies that support innovation in medical technology to address patients' healthcare needs. Medical technologies save, support, and improve lives every day around the world.
Membership of GMTA provides:
GMTA is an unincorporated entity with the members bound by agreement to a governance framework.
The GMTA meets in person twice each year (spring and fall), with teleconferencing dial-in permitted, and by online information sharing and decision-making between formal meetings.
The working language is English.
The head of an association meeting the above criteria should send an e-mail to GlobalMedicalTechnologyAlliance.Org indicating your interest in membership and a very brief explanation of how your association meets the membership criteria.
The GMTA Secretariat will acknowledge receipt of the request within 10 days.
The GMTA membership will vote on each application in accordance with its governance process.